Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)

China flag China · Delayed Price · Currency is CNY
105.13
+1.90 (1.84%)
Nov 12, 2024, 3:00 PM CST
-0.14%
Market Cap 19.93B
Revenue (ttm) 1.36B
Net Income (ttm) 369.60M
Shares Out 189.54M
EPS (ttm) 1.95
PE Ratio 53.95
Forward PE 34.47
Dividend 0.27 (0.26%)
Ex-Dividend Date Jun 5, 2024
Volume 4,489,642
Open 102.20
Previous Close 103.23
Day's Range 102.15 - 108.87
52-Week Range 65.17 - 198.47
Beta 0.51
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Eyebright Medical Technology (Beijing)

Eyebright Medical Technology (Beijing) Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases. The company was founded in 2010 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 2010
Employees 2,074
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688050
Full Company Profile

Financial Performance

In 2023, Eyebright Medical Technology (Beijing)'s revenue was 951.18 million, an increase of 64.14% compared to the previous year's 579.50 million. Earnings were 303.98 million, an increase of 30.63%.

Financial Statements

News

There is no news available yet.